How to use octreotide for malignant bowel obstruction.
Ripamonti
Carla
C
Rehabilitation and Palliative Care Operative Unit, National Cancer Institute of Milan, Italy. carla.ripamonti@istitutotumori.mi.it
Mercadante
Sebastiano
S
D000008:Abdominal Neoplasms / Q000188:drug therapy / Q000556:secondary; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015282:Octreotide / Q000627:therapeutic use*; D010386:Pelvic Neoplasms / Q000188:drug therapy / Q000556:secondary
D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D015282:Octreotide